General Information of Drug (ID: DM9R6G1)

Drug Name
Reolysinpelareorep
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 2 [1]
Cross-matching ID
TTD ID
D0CW2N

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)